| HOME >> MEDICINE >> TECHNOLOGY |
5553Additional paid-in capital
479,186465,642Accumulated deficit
(319,986)(308,426)Accumulated other comprehensive income
39585Treasury stock, at cost: 480,923 and 325,104 shares as of June 30, 2011 and December 31, 2010, respectively
(8,516)(5,225)Total stockholders’ equity
151,134152,129Total liabilities and stockholders’ equity
$291,423$
286,094NxStage Medical, Inc.Cash Flows from Operating Activities(in thousands)(unaudited)Six Months EndedJune 30,20112010Cash flows from operating activities:Net loss
$ (11,560)$ (17,255)Adjustments to reconcile net loss to netcash used in operating activities:Depreciation and amortization
11,45911,077Stock-based compensation
6,7016,875Other
1,7371,128Changes in operating assets and liabilities:Accounts receivable
(1,753)(527)Inventory
(13,363)(13,327)Prepaid expenses and other assets
(546)(404)Accounts payable
5,471(399)Accrued expenses and other liabilities
(2,446)3,060Deferred revenues
6298,745Net cash used in operating activities
$ (3,671)$ (1,027)NxStage Medical, Inc.Revenues by Segment(in thousands)Three Months EndedSix Months EndedJune 30,June 30,2011201020112010System One segment Home
$ 27,013$ 20,815$ 53,058$ 39,858 Critical Care
8,5916,65216,02912,711Total System One segment
35,60427,46769,08752,569In-Center segment
18,16416,54135,24531,847Total
$ 53,768$ 44,008$ 104,332$ 84,416NxStage Medical, Inc.Non-GAAP Financial Measures(in millions)(unaudited)Three Months EndedSix Months EndedJune 30,June 30,2011201020112010Net loss
$ (5.6)$ (8.3)$ (11.6)$ (17.3)Less: Depreciation, amortization, interest, and taxes
7.36.514.413.4Less: Adjusting items*
0.11.60.12.4Adjusted
'/>"/>
| SOURCE NxStage Medical, Inc. Copyright©2010 PR Newswire. All rights reserved |